SPRAY VEHICLE

Selank

Synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, pre-formulated as a spray vehicle.

Format

Pre-formulated spray vehicle, 10 mL multidose atomiser

Availability

IN STOCK

FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Dosage

Bundle

Total

$50

VIEW CART

STRUCTURAL DESCRIPTION

Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics (Russia) as a stable analogue of tuftsin. This spray vehicle supplies Selank in a calibrated intranasal atomiser for preclinical neuropeptide research.

MECHANISM IN RESEARCH CONTEXT

Reported to modulate GABAergic and monoaminergic systems in rodent models; investigated in nootropic-pharmacology contexts.

RELEVANT LITERATURE

Selected references

Provided for research context only. Inclusion does not imply any claim about the product or its use.

Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system
Meshavkin et al., Bull Exp Biol Med, 2006

More from this category

Semax + Selank Blend

Co-formulated intraspray vehicle containing 10 mg Semax and 10 mg Selank.

Semax

Synthetic heptapeptide fragment analogue of ACTH (4-10), pre-formulated as a spray vehicle.